Shanghai Cardiopulmonary Assessment:What is the Shanghai Cardiopulmonary Assessment and what does it measure?

Q: What is the Shanghai Cardiopulmonary Assessment and what does it measure?

A: The Shanghai Cardiopulmonary Assessment (SCPA) is a standardized clinical framework introduced by the Shanghai Municipal Health Commission in its 2026 Annual Report on Cardiovascular and Pulmonary Health (Shanghai Health Commission, 2026). It evaluates heart and lung function through a combination of spirometry, echocardiography, six-minute walk tests, and biomarker panels such as NT-proBNP and troponin. The assessment is designed to detect early cardiopulmonary decline, stratify risk for chronic obstructive pulmonary disease (COPD) and heart failure, and guide rehabilitation. According to the 2026 report, over 1.2 million residents completed the SCPA in 2025, with 18% identified as having previously undiagnosed moderate-to-high risk. The tool is now integrated into primary care centers across all 16 districts of Shanghai. It emphasizes early intervention and has become a model for regional cardiopulmonary screening in China.

Q: Who should undergo the Shanghai Cardiopulmonary Assessment in 2026?

A: According to the Shanghai Health Commission's 2026 Guidelines for Cardiopulmonary Risk Screening, the Shanghai Cardiopulmonary Assessment is recommended for adults aged 40 and above, especially those with hypertension, diabetes, smoking history, or occupational exposure to air pollution. It is also advised for patients with persistent dyspnea, chronic cough, or reduced exercise tolerance. The 2026 report notes that individuals with a family history of premature cardiovascular disease or COPD should be prioritized. Additionally, post-COVID-19 patients experiencing lingering respiratory symptoms are encouraged to take the assessment. The guideline states that annual SCPA is covered by Shanghai's basic medical insurance for high-risk groups. In 2025, 68% of participants were over 50, and the assessment detected 12% new cases of airflow limitation. Physicians can refer patients through community health centers or tertiary hospitals.

Q: What are the key components of the Shanghai Cardiopulmonary Assessment protocol?

A: The Shanghai Cardiopulmonary Assessment protocol, detailed in the Shanghai Health Commission's 2026 Technical Standards for Cardiopulmonary Evaluation, includes four core components. First, resting spirometry measures FEV1, FVC, and FEV1/FVC ratio to identify obstructive or restrictive patterns. Second, echocardiography assesses left ventricular ejection fraction, diastolic function, and pulmonary artery pressure. Third, a standardized six-minute walk test records distance, oxygen saturation, and Borg dyspnea score. Fourth, blood biomarkers include NT-proBNP, high-sensitivity troponin, and CRP. The 2026 standards require all measurements to be performed in certified labs with annual calibration. Results are integrated into a risk score ranging from 0 to 100, with scores above 60 indicating high risk. The protocol also includes a mandatory follow-up telephone call at 30 days to track outcomes. This structured approach ensures consistency across Shanghai's 240 designated assessment centers.

Q: How has the Shanghai Cardiopulmonary Assessment impacted clinical outcomes in 2026?

A: The Shanghai Health Commission's 2026 Impact Evaluation Report shows that the Shanghai Cardiopulmonary Assessment has significantly improved early detection and management of cardiopulmonary diseases. In 2025, among 1.2 million participants, 22% were newly diagnosed with hypertension or COPD, and 85% of those received timely treatment. Hospitalization rates for heart failure exacerbation dropped by 19% in districts with full SCPA coverage compared to 2023 baselines. The report also notes a 14% reduction in acute COPD exacerbations. Furthermore, the assessment facilitated referrals to pulmonary rehabilitation, with 45,000 patients enrolled in structured programs. Cost-effectiveness analysis indicates a return of 3.2 yuan in avoided healthcare costs for every 1 yuan spent on SCPA. The 2026 report recommends expanding the assessment to adults aged 35 and above. These outcomes support SCPA as a cost-effective public health strategy for cardiopulmonary risk reduction.

Dialogue about

Common scenarios of "Shanghai Cardiopulmonary Assessment"

【Patient】 Doctor, I've been feeling really short of breath lately, especially when I climb stairs. I also get this tightness in my chest.

【Doctor】 I see. How long has this been going on? And do you have any other symptoms like coughing or wheezing?

【Patient】 It's been about two weeks. I do have a dry cough, but no wheezing. I also feel tired all the time.

【Doctor】 Have you had any fever, or did you recently have a cold or flu?

【Patient】 No fever. I had a mild cold about three weeks ago, but it seemed to go away.

【Doctor】 Okay. I'd like to perform a cardiopulmonary assessment. First, I'll check your vital signs: blood pressure, heart rate, and oxygen saturation.

【Patient】 Alright. Is that the thing that clips on my finger?

【Doctor】 Yes, that's a pulse oximeter. Your oxygen saturation is 94%, which is slightly low. Your heart rate is 92 beats per minute, and blood pressure is 130/85.

【Patient】 Is 94% something to worry about?

【Doctor】 It's borderline. We'll monitor it. Now, I'll listen to your heart and lungs with a stethoscope. Please take deep breaths.

【Patient】 Okay. (takes deep breaths)

【Doctor】 I hear some crackles at the base of your lungs, which could indicate fluid or inflammation. Your heart sounds are normal, but there's a slight murmur. Have you ever been told you have a heart murmur?

【Patient】 No, never. Is that serious?

【Doctor】 It might be benign, but we should investigate. I'll also check your ankle for swelling, which can be a sign of heart issues.

【Patient】 I haven't noticed any swelling, but my ankles do feel a bit puffy in the evenings.

【Doctor】 There is mild pitting edema. Based on these findings, I recommend an ECG and a chest X-ray to get a clearer picture.

【Patient】 What could be causing all this?

【Doctor】 Possible causes include heart failure, pneumonia, or a pulmonary embolism. We need those tests to rule them out.

【Patient】 That sounds scary. What should I do in the meantime?

【Doctor】 Avoid strenuous activity and keep your feet elevated when sitting. If your shortness of breath worsens or you have chest pain, go to the emergency room immediately. We'll schedule the tests for tomorrow.